AU2022902836A0 - SARS-CoV-2 antibodies - Google Patents

SARS-CoV-2 antibodies

Info

Publication number
AU2022902836A0
AU2022902836A0 AU2022902836A AU2022902836A AU2022902836A0 AU 2022902836 A0 AU2022902836 A0 AU 2022902836A0 AU 2022902836 A AU2022902836 A AU 2022902836A AU 2022902836 A AU2022902836 A AU 2022902836A AU 2022902836 A0 AU2022902836 A0 AU 2022902836A0
Authority
AU
Australia
Prior art keywords
cov
sars
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022902836A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Garvan Institute of Medical Research
Original Assignee
Garvan Institute of Medical Research
Filing date
Publication date
Application filed by Garvan Institute of Medical Research filed Critical Garvan Institute of Medical Research
Publication of AU2022902836A0 publication Critical patent/AU2022902836A0/en
Pending legal-status Critical Current

Links

AU2022902836A 2022-09-30 SARS-CoV-2 antibodies Pending AU2022902836A0 (en)

Publications (1)

Publication Number Publication Date
AU2022902836A0 true AU2022902836A0 (en) 2022-10-20

Family

ID=

Similar Documents

Publication Publication Date Title
EP3986936A4 (en) Anti-tigit antibodies
EP4144370A4 (en) Bispecific antibody
EP4081546A4 (en) Novel anti-fgfr2b antibodies
EP4165079A4 (en) Hiv-1 antibodies
EP3986462A4 (en) Anti-tim-3 antibodies
EP3995582A4 (en) Anti-epha4 antibody
EP4081539A4 (en) Novel anti-fgfr2b antibodies
EP4081547A4 (en) Novel anti-fgfr2b antibodies
EP3917965A4 (en) Novel anti-ifnar1 antibodies
EP4121110A4 (en) Anti-ceramide antibodies
EP4163301A4 (en) Humanized anti-gpc-1 antibody
EP4070816A4 (en) Anti-gdf15 antibody
AU2023238937A1 (en) Anti-par2 antibodies
AU2022902836A0 (en) SARS-CoV-2 antibodies
AU2022902742A0 (en) Anti-CCR8 antibodies
EP3980456A4 (en) Affinity-maturated anti-asic1a antibodies
AU2023238433A1 (en) Zip12 antibody
AU2020904811A0 (en) SARS-CoV-2 antibodies
AU2020904813A0 (en) SARS-CoV-2 antibodies
AU2020903586A0 (en) Clec9A antibodies
AU2023901311A0 (en) Structurally constrained antibodies
TWI859446B (en) Anti-pd-1 antibodies
GB2614651B (en) Antibodies
AU2023900642A0 (en) Multifunctional antibodies
AU2022902552A0 (en) Multifunctional antibodies